| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.28B | +16.5% |
| Cost of Revenue | $1.06B | -15.7% |
| R&D Expense | $592.4M | +16.7% |
| SG&A Expense | $152.6M | -16.0% |
| Operating Income | $648.2M | +1456.3% |
| Interest Expense | $275.7M | +60.4% |
| Pre-tax Income | $380.6M | +285.5% |
| Income Tax | $23.9M | +295.1% |
| Net Income | $356.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $502.2M | -53.5% |
| Accounts Receivable | $953.8M | +35.7% |
| Current Assets | $1.62B | -16.7% |
| Total Assets | $5.36B | -8.4% |
| Current Liabilities | $944.1M | +63.1% |
| Long-term Debt | $3.12B | -2.8% |
| Total Liabilities | $4.10B | +4.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.06B | +157.2% |
| Capital Expenditures | $4.2M | +541.4% |
| Investing Cash Flow | -$77.8M | +94.3% |
| Financing Cash Flow | -$1.56B | -196.6% |
| Free Cash Flow | $1.06B | +156.5% |
| +285.1% |
| EPS (Basic) | $1.01 | +294.2% |
| EPS (Diluted) | $0.98 | +288.5% |
| Stockholders' Equity |
| $1.26B |
| -34.0% |